06/23/2026
AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, established its U.S. Global Headquarters in the Greater Boston area, and leased a new 128,000-sq.-ft. facility that will serve as its U.S. flagship manufacturing center. ➡️ https://hubs.li/Q04mkqZC0